{
  "_originalData": {
    "identity": {
      "bacteriumName": "Brucella sp.",
      "aliases": [
        "Brucellosis",
        "Malta fever",
        "Mediterranean fever",
        "Undulant fever"
      ],
      "lastUpdated": "2023-09-12",
      "clsiCategory": "Not classified by CLSI",
      "classification": {
        "gramStain": "Gram-negative",
        "morphology": "Coccobacillus",
        "respiration": "Aerobic",
        "notes": [
          "Slow growing"
        ]
      },
      "strainDetails": [
        {
          "type": "Species",
          "value": "Brucella melitensis",
          "notes": ""
        },
        {
          "type": "Species",
          "value": "Brucella abortus",
          "notes": ""
        },
        {
          "type": "Species",
          "value": "Brucella suis",
          "notes": ""
        },
        {
          "type": "Species",
          "value": "Brucella canis",
          "notes": ""
        }
      ],
      "biochemicalTests": "Gram-negative coccobacillus, aerobic, slow-growing, non-motile, catalase +, oxidase +, urease + (rapidly for B. suis and B. canis)."
    },
    "clinicalProfile": {
      "summary": "Brucellosis is a zoonotic infection caused by Brucella species, typically transmitted through unpasteurized dairy or contact with infected animals. It presents with a wide range of symptoms, from a non-specific febrile illness to focal infections like osteoarticular disease, and rarely, endocarditis.",
      "pathophysiologyPearls": [
        "Brucella is an intracellular pathogen that can survive and replicate within phagocytic cells, leading to chronic and relapsing infections."
      ],
      "keySignsAndSymptoms": [
        "Fever (in 90% of cases, often undulant)",
        "Malodorous perspiration (pathognomonic but uncommon)",
        "Arthralgia and myalgia",
        "Headache",
        "Fatigue",
        "Leukopenia and relative lymphocytosis",
        "Mild hepatitis"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Febrile illness",
          "description": "A non-specific presentation with fever, sweats, malaise, and anorexia."
        },
        {
          "syndromeName": "Osteoarticular disease",
          "description": "Occurs in 20-30% of cases, with sacroiliitis being a common manifestation."
        },
        {
          "syndromeName": "Neurobrucellosis",
          "description": "A rare but serious complication that can manifest as meningitis, encephalitis, or myelitis."
        },
        {
          "syndromeName": "Endocarditis",
          "description": "A rare but life-threatening complication requiring both medical and surgical intervention."
        }
      ],
      "highRiskPopulations": [
        "Farmers, veterinarians, and slaughterhouse workers",
        "Consumers of unpasteurized dairy products",
        "Laboratory personnel working with Brucella cultures"
      ],
      "transmissionVectors": [
        "Ingestion of unpasteurized dairy products",
        "Direct contact with infected animals, their tissues, or secretions"
      ],
      "prognosisNotes": [
        "Relapse rate after treatment is approximately 10%."
      ]
    },
    "resistanceProfile": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [
        {
          "drugOrClass": "Rifampin",
          "notes": "B. abortus strain RB51 is resistant to Rifampin."
        }
      ],
      "majorMechanisms": [],
      "clinicalAlerts": []
    },
    "treatment": {
      "generalNotes": [
        "Combination therapy is preferred to decrease the risk of relapse.",
        "Prolonged duration of therapy is often necessary."
      ],
      "drugsToAvoid": [],
      "adjunctiveTherapies": [
        {
          "therapy": "Surgery",
          "condition": "Endocarditis",
          "details": "Almost always required in addition to antibiotic therapy."
        }
      ],
      "regimens": [
        {
          "context": {
            "type": "Directed",
            "condition": "Non-localizing disease",
            "patientPopulation": [
              "Adults",
              "Children > 8 years"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "6 weeks",
                  "drugs": [
                    {
                      "drugName": "Doxycycline",
                      "dose": "100 mg",
                      "route": "PO",
                      "frequency": "BID",
                      "comments": ""
                    }
                  ]
                },
                {
                  "step": 2,
                  "duration": "7 days",
                  "drugs": [
                    {
                      "drugName": "Gentamicin",
                      "dose": "5 mg/kg",
                      "route": "IV",
                      "frequency": "once daily",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "6 weeks",
                  "drugs": [
                    {
                      "drugName": "Doxycycline",
                      "dose": "100 mg",
                      "route": "PO",
                      "frequency": "BID",
                      "comments": ""
                    },
                    {
                      "drugName": "Rifampin",
                      "dose": "600-900 mg",
                      "route": "PO",
                      "frequency": "once daily",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Directed",
            "condition": "Non-localizing disease",
            "patientPopulation": [
              "Children < 8 years"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "6 weeks",
                  "drugs": [
                    {
                      "drugName": "TMP-SMX",
                      "dose": "5 mg/kg (TMP component)",
                      "route": "PO",
                      "frequency": "q12h",
                      "comments": ""
                    },
                    {
                      "drugName": "Rifampin",
                      "dose": "15-20 mg/kg (max 900 mg/day)",
                      "route": "PO",
                      "frequency": "divided in one or two doses",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Directed",
            "condition": "Spondylitis/Sacroiliitis/Arthritis",
            "patientPopulation": [
              "Adults"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": ">= 12 weeks",
                  "drugs": [
                    {
                      "drugName": "Doxycycline",
                      "dose": "100 mg",
                      "route": "PO",
                      "frequency": "BID",
                      "comments": ""
                    },
                    {
                      "drugName": "Rifampin",
                      "dose": "600-900 mg",
                      "route": "PO",
                      "frequency": "once daily",
                      "comments": ""
                    }
                  ]
                },
                {
                  "step": 2,
                  "duration": "7-14 days",
                  "drugs": [
                    {
                      "drugName": "Gentamicin",
                      "dose": "5 mg/kg",
                      "route": "IM/IV",
                      "frequency": "once daily",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": ">= 3 months",
                  "drugs": [
                    {
                      "drugName": "Ciprofloxacin",
                      "dose": "750 mg",
                      "route": "PO",
                      "frequency": "BID",
                      "comments": ""
                    },
                    {
                      "drugName": "Rifampin",
                      "dose": "600-900 mg",
                      "route": "PO",
                      "frequency": "once daily",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Directed",
            "condition": "Spondylitis/Sacroiliitis/Arthritis",
            "patientPopulation": [
              "Children >= 8 years"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": ">= 12 weeks",
                  "drugs": [
                    {
                      "drugName": "Doxycycline",
                      "dose": "4.4 mg/kg/day (max 200mg/day)",
                      "route": "PO",
                      "frequency": "in 2 divided doses",
                      "comments": ""
                    },
                    {
                      "drugName": "Rifampin",
                      "dose": "15-20 mg/kg/day (max 900mg/day)",
                      "route": "PO",
                      "frequency": "once daily",
                      "comments": ""
                    }
                  ]
                },
                {
                  "step": 2,
                  "duration": "7-14 days",
                  "drugs": [
                    {
                      "drugName": "Gentamicin",
                      "dose": "5 mg/kg",
                      "route": "IV/IM",
                      "frequency": "once daily",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Directed",
            "condition": "Spondylitis/Sacroiliitis/Arthritis",
            "patientPopulation": [
              "Children < 8 years"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": ">= 12 weeks",
                  "drugs": [
                    {
                      "drugName": "TMP-SMX",
                      "dose": "10 mg/kg/day TMP (max. 320 mg/day), 50 mg/kg/day SMX (max. 1.6 mg/day)",
                      "route": "PO",
                      "frequency": "in 2 divided doses",
                      "comments": ""
                    },
                    {
                      "drugName": "Rifampin",
                      "dose": "15-20 mg/kg/day (max. 900 mg/day)",
                      "route": "PO",
                      "frequency": "once daily",
                      "comments": ""
                    }
                  ]
                },
                {
                  "step": 2,
                  "duration": "7-14 days",
                  "drugs": [
                    {
                      "drugName": "Gentamicin",
                      "dose": "5 mg/kg",
                      "route": "IV/IM",
                      "frequency": "once daily",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Directed",
            "condition": "Pregnancy (<36 weeks gestation)",
            "patientPopulation": [
              "Pregnant women"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "4 weeks",
                  "drugs": [
                    {
                      "drugName": "TMP-SMX",
                      "dose": "5 mg/kg of TMP component",
                      "route": "PO",
                      "frequency": "BID",
                      "comments": ""
                    },
                    {
                      "drugName": "Rifampin",
                      "dose": "600-900 mg",
                      "route": "PO",
                      "frequency": "q24h",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Directed",
            "condition": "Pregnancy (>=36 weeks gestation)",
            "patientPopulation": [
              "Pregnant women"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "Until delivery",
                  "drugs": [
                    {
                      "drugName": "Rifampin",
                      "dose": "",
                      "route": "",
                      "frequency": "",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Directed",
            "condition": "Neurobrucellosis",
            "patientPopulation": [
              "General"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "Until CSF is normal",
                  "drugs": [
                    {
                      "drugName": "Doxycycline",
                      "dose": "100 mg",
                      "route": "IV/PO",
                      "frequency": "BID",
                      "comments": ""
                    },
                    {
                      "drugName": "Rifampin",
                      "dose": "600-900 mg",
                      "route": "PO",
                      "frequency": "once daily",
                      "comments": ""
                    },
                    {
                      "drugName": "Ceftriaxone",
                      "dose": "2 gm",
                      "route": "IV",
                      "frequency": "q12h",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Directed",
            "condition": "Endocarditis",
            "patientPopulation": [
              "General"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "6 weeks to 6 months",
                  "drugs": [
                    {
                      "drugName": "Rifampin",
                      "dose": "",
                      "route": "",
                      "frequency": "",
                      "comments": ""
                    },
                    {
                      "drugName": "Doxycycline",
                      "dose": "",
                      "route": "",
                      "frequency": "",
                      "comments": ""
                    },
                    {
                      "drugName": "TMP-SMX",
                      "dose": "",
                      "route": "",
                      "frequency": "",
                      "comments": ""
                    }
                  ]
                },
                {
                  "step": 2,
                  "duration": "2-4 weeks",
                  "drugs": [
                    {
                      "drugName": "Gentamicin",
                      "dose": "5 mg/kg",
                      "route": "IV",
                      "frequency": "once daily",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": [
                "Almost always need surgery plus antibiotics."
              ]
            }
          ]
        }
      ]
    },
    "laboratoryProfile": {
      "testingIndications": [
        "Febrile illness with a history of exposure to unpasteurized dairy products or infected animals.",
        "Osteoarticular infection, especially sacroiliitis."
      ],
      "methodologyNotes": [
        "False negative serology can occur due to the prozone phenomenon."
      ],
      "recommendedPanel": [],
      "specialTests": [
        {
          "testName": "Serology",
          "trigger": "Clinical suspicion of brucellosis",
          "purpose": "To detect antibodies against Brucella sp. All positive rapid serologies require confirmation with Brucella sp. specific agglutination."
        },
        {
          "testName": "Bone marrow culture",
          "trigger": "High clinical suspicion with negative blood cultures",
          "purpose": "To isolate Brucella sp."
        },
        {
          "testName": "PCR",
          "trigger": "When available and certified",
          "purpose": "For sensitive and specific detection of Brucella DNA."
        }
      ],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    },
    "additionalInformation": {
      "diagnosticNotes": {
        "summary": "Diagnosis is made by a combination of clinical suspicion, serology, and culture or molecular methods.",
        "biosafetyWarning": "Inform the laboratory of possible brucellosis to lower the risk of occupational exposure (BSL-3 practices recommended for culture).",
        "methods": [
          {
            "methodName": "Serology",
            "details": "Remains a useful diagnostic tool, especially in resource-limited settings. Confirmation of positive rapid tests is necessary."
          },
          {
            "methodName": "Culture",
            "details": "Blood and bone marrow cultures can be positive, but growth is slow."
          },
          {
            "methodName": "NAAT",
            "details": "PCR and 16S rRNA gene sequencing are the most sensitive and specific methods when available."
          }
        ]
      },
      "preventionAndScreening": [
        {
          "type": "Prophylaxis",
          "details": "Post-exposure prophylaxis with Doxycycline + Rifampin for 3 weeks is recommended after laboratory exposure. If B. abortus strain RB51 is suspected, use Doxycycline alone. If Doxycycline is not tolerated or in pregnancy, use TMP-SMX with or without Rifampin.",
          "targetPopulation": "Laboratory personnel with exposure to Brucella."
        }
      ],
      "treatmentLifecycle": [
        {
          "topic": "Test of Cure",
          "details": "Antibody testing of exposed personnel via State labs or CDC at 2, 4, 6 and 24 weeks. Note the poor antibody response to B. abortus strain RB51."
        }
      ],
      "antimicrobialStewardship": [],
      "drugSpecificPearls": [],
      "guidelineReferences": [
        {
          "source": "CDC",
          "citation": "",
          "summaryOrNote": "CDC guidance on Brucella infections in humans."
        },
        {
          "source": "Antimicrob Agents Chemother",
          "citation": "58:7541, 2014",
          "summaryOrNote": "Observational study reports higher frequency (p 0.026) of clearance of Brucella DNA from whole blood with triple therapy: (Gentamicin or Streptomycin) + Doxycycline + Rifampin."
        },
        {
          "source": "N Engl J Med",
          "citation": "352:2325, 2005",
          "summaryOrNote": "Brucellosis review."
        },
        {
          "source": "PLoS One",
          "citation": "7:e32090, 2012",
          "summaryOrNote": "Brucellosis review."
        },
        {
          "source": "Clin Infect Dis",
          "citation": "56:1407, 2013",
          "summaryOrNote": "Brucellosis review."
        },
        {
          "source": "MMWR",
          "citation": "61:461, 2012",
          "summaryOrNote": "Refs for arthritis."
        },
        {
          "source": "Clin Micro Rev",
          "citation": "2019;33: e00073",
          "summaryOrNote": "Reference for diagnosis."
        }
      ]
    }
  },
  "_metadata": {
    "originalKeys": [
      "identity",
      "clinicalProfile",
      "resistanceProfile",
      "treatment",
      "laboratoryProfile",
      "additionalInformation"
    ],
    "conversionTimestamp": "2025-07-15T03:16:49.365Z",
    "sourceFormat": "modern"
  },
  "identity": {
    "bacteriumName": {
      "sources": [
        "identity.bacteriumName"
      ],
      "value": "Brucella sp."
    },
    "aliases": {
      "sources": [
        "identity.aliases"
      ],
      "value": [
        "Brucellosis",
        "Malta fever",
        "Mediterranean fever",
        "Undulant fever"
      ]
    },
    "lastUpdated": {
      "sources": [
        "identity.lastUpdated"
      ],
      "value": "2023-09-12"
    },
    "classification": {
      "sources": [
        "identity.classification"
      ],
      "value": {
        "gramStain": "Gram-negative",
        "morphology": "Coccobacillus",
        "respiration": "Aerobic",
        "notes": [
          "Slow growing"
        ]
      }
    }
  },
  "clinicalInformation": {
    "sources": [
      "clinicalProfile"
    ],
    "value": {
      "summary": "Brucellosis is a zoonotic infection caused by Brucella species, typically transmitted through unpasteurized dairy or contact with infected animals. It presents with a wide range of symptoms, from a non-specific febrile illness to focal infections like osteoarticular disease, and rarely, endocarditis.",
      "pathophysiologyPearls": [
        "Brucella is an intracellular pathogen that can survive and replicate within phagocytic cells, leading to chronic and relapsing infections."
      ],
      "keySignsAndSymptoms": [
        "Fever (in 90% of cases, often undulant)",
        "Malodorous perspiration (pathognomonic but uncommon)",
        "Arthralgia and myalgia",
        "Headache",
        "Fatigue",
        "Leukopenia and relative lymphocytosis",
        "Mild hepatitis"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Febrile illness",
          "description": "A non-specific presentation with fever, sweats, malaise, and anorexia."
        },
        {
          "syndromeName": "Osteoarticular disease",
          "description": "Occurs in 20-30% of cases, with sacroiliitis being a common manifestation."
        },
        {
          "syndromeName": "Neurobrucellosis",
          "description": "A rare but serious complication that can manifest as meningitis, encephalitis, or myelitis."
        },
        {
          "syndromeName": "Endocarditis",
          "description": "A rare but life-threatening complication requiring both medical and surgical intervention."
        }
      ],
      "highRiskPopulations": [
        "Farmers, veterinarians, and slaughterhouse workers",
        "Consumers of unpasteurized dairy products",
        "Laboratory personnel working with Brucella cultures"
      ],
      "transmissionVectors": [
        "Ingestion of unpasteurized dairy products",
        "Direct contact with infected animals, their tissues, or secretions"
      ],
      "prognosisNotes": [
        "Relapse rate after treatment is approximately 10%."
      ]
    }
  },
  "resistanceInformation": {
    "sources": [
      "resistanceProfile"
    ],
    "value": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [
        {
          "drugOrClass": "Rifampin",
          "notes": "B. abortus strain RB51 is resistant to Rifampin."
        }
      ],
      "majorMechanisms": [],
      "clinicalAlerts": []
    }
  },
  "treatmentData": {
    "treatmentData": {
      "_treatmentMetadata": {
        "originalFormat": "modern"
      },
      "standardizedRegimens": [
        {
          "regimenId": "modern-0-0-0",
          "extractedFrom": "treatment.regimens[0].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Non-localizing disease",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults",
                "Children > 8 years"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Doxycycline",
              "dose": "100 mg",
              "route": "PO",
              "frequency": "BID",
              "duration": "6 weeks",
              "comments": "",
              "originalText": "Doxycycline 100 mg PO BID"
            }
          ]
        },
        {
          "regimenId": "modern-0-0-1",
          "extractedFrom": "treatment.regimens[0].recommendations[0].steps[1]",
          "context": {
            "type": "directed",
            "condition": "Non-localizing disease",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults",
                "Children > 8 years"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Gentamicin",
              "dose": "5 mg/kg",
              "route": "IV",
              "frequency": "once daily",
              "duration": "7 days",
              "comments": "",
              "originalText": "Gentamicin 5 mg/kg IV once daily"
            }
          ]
        },
        {
          "regimenId": "modern-0-1-0",
          "extractedFrom": "treatment.regimens[0].recommendations[1].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Non-localizing disease",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults",
                "Children > 8 years"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Doxycycline",
              "dose": "100 mg",
              "route": "PO",
              "frequency": "BID",
              "duration": "6 weeks",
              "comments": "",
              "originalText": "Doxycycline 100 mg PO BID"
            },
            {
              "drugName": "Rifampin",
              "dose": "600-900 mg",
              "route": "PO",
              "frequency": "once daily",
              "duration": "6 weeks",
              "comments": "",
              "originalText": "Rifampin 600-900 mg PO once daily"
            }
          ]
        },
        {
          "regimenId": "modern-1-0-0",
          "extractedFrom": "treatment.regimens[1].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Non-localizing disease",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Children < 8 years"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "TMP-SMX",
              "dose": "5 mg/kg (TMP component)",
              "route": "PO",
              "frequency": "q12h",
              "duration": "6 weeks",
              "comments": "",
              "originalText": "TMP-SMX 5 mg/kg (TMP component) PO q12h"
            },
            {
              "drugName": "Rifampin",
              "dose": "15-20 mg/kg (max 900 mg/day)",
              "route": "PO",
              "frequency": "divided in one or two doses",
              "duration": "6 weeks",
              "comments": "",
              "originalText": "Rifampin 15-20 mg/kg (max 900 mg/day) PO divided in one or two doses"
            }
          ]
        },
        {
          "regimenId": "modern-2-0-0",
          "extractedFrom": "treatment.regimens[2].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Spondylitis/Sacroiliitis/Arthritis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Doxycycline",
              "dose": "100 mg",
              "route": "PO",
              "frequency": "BID",
              "duration": ">= 12 weeks",
              "comments": "",
              "originalText": "Doxycycline 100 mg PO BID"
            },
            {
              "drugName": "Rifampin",
              "dose": "600-900 mg",
              "route": "PO",
              "frequency": "once daily",
              "duration": ">= 12 weeks",
              "comments": "",
              "originalText": "Rifampin 600-900 mg PO once daily"
            }
          ]
        },
        {
          "regimenId": "modern-2-0-1",
          "extractedFrom": "treatment.regimens[2].recommendations[0].steps[1]",
          "context": {
            "type": "directed",
            "condition": "Spondylitis/Sacroiliitis/Arthritis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Gentamicin",
              "dose": "5 mg/kg",
              "route": "IM/IV",
              "frequency": "once daily",
              "duration": "7-14 days",
              "comments": "",
              "originalText": "Gentamicin 5 mg/kg IM/IV once daily"
            }
          ]
        },
        {
          "regimenId": "modern-2-1-0",
          "extractedFrom": "treatment.regimens[2].recommendations[1].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Spondylitis/Sacroiliitis/Arthritis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Ciprofloxacin",
              "dose": "750 mg",
              "route": "PO",
              "frequency": "BID",
              "duration": ">= 3 months",
              "comments": "",
              "originalText": "Ciprofloxacin 750 mg PO BID"
            },
            {
              "drugName": "Rifampin",
              "dose": "600-900 mg",
              "route": "PO",
              "frequency": "once daily",
              "duration": ">= 3 months",
              "comments": "",
              "originalText": "Rifampin 600-900 mg PO once daily"
            }
          ]
        },
        {
          "regimenId": "modern-3-0-0",
          "extractedFrom": "treatment.regimens[3].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Spondylitis/Sacroiliitis/Arthritis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Children >= 8 years"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Doxycycline",
              "dose": "4.4 mg/kg/day (max 200mg/day)",
              "route": "PO",
              "frequency": "in 2 divided doses",
              "duration": ">= 12 weeks",
              "comments": "",
              "originalText": "Doxycycline 4.4 mg/kg/day (max 200mg/day) PO in 2 divided doses"
            },
            {
              "drugName": "Rifampin",
              "dose": "15-20 mg/kg/day (max 900mg/day)",
              "route": "PO",
              "frequency": "once daily",
              "duration": ">= 12 weeks",
              "comments": "",
              "originalText": "Rifampin 15-20 mg/kg/day (max 900mg/day) PO once daily"
            }
          ]
        },
        {
          "regimenId": "modern-3-0-1",
          "extractedFrom": "treatment.regimens[3].recommendations[0].steps[1]",
          "context": {
            "type": "directed",
            "condition": "Spondylitis/Sacroiliitis/Arthritis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Children >= 8 years"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Gentamicin",
              "dose": "5 mg/kg",
              "route": "IV/IM",
              "frequency": "once daily",
              "duration": "7-14 days",
              "comments": "",
              "originalText": "Gentamicin 5 mg/kg IV/IM once daily"
            }
          ]
        },
        {
          "regimenId": "modern-4-0-0",
          "extractedFrom": "treatment.regimens[4].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Spondylitis/Sacroiliitis/Arthritis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Children < 8 years"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "TMP-SMX",
              "dose": "10 mg/kg/day TMP (max. 320 mg/day), 50 mg/kg/day SMX (max. 1.6 mg/day)",
              "route": "PO",
              "frequency": "in 2 divided doses",
              "duration": ">= 12 weeks",
              "comments": "",
              "originalText": "TMP-SMX 10 mg/kg/day TMP (max. 320 mg/day), 50 mg/kg/day SMX (max. 1.6 mg/day) PO in 2 divided doses"
            },
            {
              "drugName": "Rifampin",
              "dose": "15-20 mg/kg/day (max. 900 mg/day)",
              "route": "PO",
              "frequency": "once daily",
              "duration": ">= 12 weeks",
              "comments": "",
              "originalText": "Rifampin 15-20 mg/kg/day (max. 900 mg/day) PO once daily"
            }
          ]
        },
        {
          "regimenId": "modern-4-0-1",
          "extractedFrom": "treatment.regimens[4].recommendations[0].steps[1]",
          "context": {
            "type": "directed",
            "condition": "Spondylitis/Sacroiliitis/Arthritis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Children < 8 years"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Gentamicin",
              "dose": "5 mg/kg",
              "route": "IV/IM",
              "frequency": "once daily",
              "duration": "7-14 days",
              "comments": "",
              "originalText": "Gentamicin 5 mg/kg IV/IM once daily"
            }
          ]
        },
        {
          "regimenId": "modern-5-0-0",
          "extractedFrom": "treatment.regimens[5].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Pregnancy (<36 weeks gestation)",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Pregnant women"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "TMP-SMX",
              "dose": "5 mg/kg of TMP component",
              "route": "PO",
              "frequency": "BID",
              "duration": "4 weeks",
              "comments": "",
              "originalText": "TMP-SMX 5 mg/kg of TMP component PO BID"
            },
            {
              "drugName": "Rifampin",
              "dose": "600-900 mg",
              "route": "PO",
              "frequency": "q24h",
              "duration": "4 weeks",
              "comments": "",
              "originalText": "Rifampin 600-900 mg PO q24h"
            }
          ]
        },
        {
          "regimenId": "modern-6-0-0",
          "extractedFrom": "treatment.regimens[6].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Pregnancy (>=36 weeks gestation)",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Pregnant women"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Rifampin",
              "dose": "",
              "route": "",
              "frequency": "",
              "duration": "Until delivery",
              "comments": "",
              "originalText": "Rifampin   "
            }
          ]
        },
        {
          "regimenId": "modern-7-0-0",
          "extractedFrom": "treatment.regimens[7].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Neurobrucellosis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Doxycycline",
              "dose": "100 mg",
              "route": "IV/PO",
              "frequency": "BID",
              "duration": "Until CSF is normal",
              "comments": "",
              "originalText": "Doxycycline 100 mg IV/PO BID"
            },
            {
              "drugName": "Rifampin",
              "dose": "600-900 mg",
              "route": "PO",
              "frequency": "once daily",
              "duration": "Until CSF is normal",
              "comments": "",
              "originalText": "Rifampin 600-900 mg PO once daily"
            },
            {
              "drugName": "Ceftriaxone",
              "dose": "2 gm",
              "route": "IV",
              "frequency": "q12h",
              "duration": "Until CSF is normal",
              "comments": "",
              "originalText": "Ceftriaxone 2 gm IV q12h"
            }
          ]
        },
        {
          "regimenId": "modern-8-0-0",
          "extractedFrom": "treatment.regimens[8].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Endocarditis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Rifampin",
              "dose": "",
              "route": "",
              "frequency": "",
              "duration": "6 weeks to 6 months",
              "comments": "",
              "originalText": "Rifampin   "
            },
            {
              "drugName": "Doxycycline",
              "dose": "",
              "route": "",
              "frequency": "",
              "duration": "6 weeks to 6 months",
              "comments": "",
              "originalText": "Doxycycline   "
            },
            {
              "drugName": "TMP-SMX",
              "dose": "",
              "route": "",
              "frequency": "",
              "duration": "6 weeks to 6 months",
              "comments": "",
              "originalText": "TMP-SMX   "
            }
          ]
        },
        {
          "regimenId": "modern-8-0-1",
          "extractedFrom": "treatment.regimens[8].recommendations[0].steps[1]",
          "context": {
            "type": "directed",
            "condition": "Endocarditis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Gentamicin",
              "dose": "5 mg/kg",
              "route": "IV",
              "frequency": "once daily",
              "duration": "2-4 weeks",
              "comments": "",
              "originalText": "Gentamicin 5 mg/kg IV once daily"
            }
          ]
        }
      ]
    }
  },
  "laboratoryData": {
    "sources": [
      "laboratoryProfile"
    ],
    "value": {
      "testingIndications": [
        "Febrile illness with a history of exposure to unpasteurized dairy products or infected animals.",
        "Osteoarticular infection, especially sacroiliitis."
      ],
      "methodologyNotes": [
        "False negative serology can occur due to the prozone phenomenon."
      ],
      "recommendedPanel": [],
      "specialTests": [
        {
          "testName": "Serology",
          "trigger": "Clinical suspicion of brucellosis",
          "purpose": "To detect antibodies against Brucella sp. All positive rapid serologies require confirmation with Brucella sp. specific agglutination."
        },
        {
          "testName": "Bone marrow culture",
          "trigger": "High clinical suspicion with negative blood cultures",
          "purpose": "To isolate Brucella sp."
        },
        {
          "testName": "PCR",
          "trigger": "When available and certified",
          "purpose": "For sensitive and specific detection of Brucella DNA."
        }
      ],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    }
  },
  "additionalData": {
    "antimicrobialStewardship": {
      "sources": [
        "antimicrobial_stewardship",
        "antimicrobialStewardship"
      ],
      "value": []
    },
    "comments": {
      "preservedStructure": {
        "originalFormat": "object"
      }
    },
    "diagnosis": {
      "sources": [
        "diagnosis"
      ],
      "value": []
    },
    "allOtherKeys": {}
  }
}